Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...

Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

As with any prescription medication, there are side effects of Wegovy to keep in mind. The most common side effects are ...

In a closed-door meeting at Novo's Denmark headquarters about two months ago, the India team raised concerns that the company ...